BioCentury
ARTICLE | Finance

Buyside tracks

Biotech investor, banker and analyst personnel changes

October 10, 2011 7:00 AM UTC

Stefan Mueller will depart from BB Biotech. His plans haven't been announced.

Andy Smith joined advisory firm PharmaVentures as head of corporate finance. Last year, he left his position of biotechnology fund manager at AXA Framlington...